Intuitive Surgical (ISRG) Cash & Current Investments (2009 - 2026)
Intuitive Surgical (ISRG) recorded quarterly Cash & Current Investments of $4.5 billion in Q1 2026, down 23.89% quarter-over-quarter from $5.9 billion in Q4 2025, and down 0.82% on a YoY basis from $4.6 billion in Q1 2025.
Intuitive Surgical (ISRG) Cash & Current Investments (2009 - 2026) Analysis & Trends
Intuitive Surgical's Cash & Current Investments history runs 18 years deep, the most recent figure standing at $4.5 billion for Q1 2026.
- In Q1 2026, Cash & Current Investments fell 0.82% year-over-year to $4.5 billion; the TTM figure through Mar 2026 stood at $4.5 billion (down 0.82% YoY), while the FY2025 annual figure was $5.9 billion, up 46.6% from the prior year.
- Cash & Current Investments was $4.5 billion for Q1 2026 at Intuitive Surgical, down from $5.9 billion in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $6.5 billion in Q3 2023 to a low of $4.0 billion in Q1 2022.
- Historically, Cash & Current Investments has averaged $4.8 billion across 5 years, with a median of $4.7 billion in 2023.
- The sharpest annual moves came in 2023 and 2024: Cash & Current Investments jumped 50.11% in 2023, then tumbled 34.14% in 2024.
- A 5-year view of Cash & Current Investments shows it stood at $4.1 billion in 2022, then increased by 27.33% to $5.2 billion in 2023, then dropped by 22.79% to $4.0 billion in 2024, then jumped by 46.6% to $5.9 billion in 2025, then fell by 23.89% to $4.5 billion in 2026.
- The last three Cash & Current Investments figures came in at $4.5 billion (Q1 2026), $5.9 billion (Q4 2025), and $4.9 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 4.52 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.02 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 2.24 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.66 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 521.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 138.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.06 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.02 Bn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 229.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.52 Bn |
| Dec 31, 2025 | 5.93 Bn |
| Sep 30, 2025 | 4.91 Bn |
| Jun 30, 2025 | 5.33 Bn |
| Mar 31, 2025 | 4.55 Bn |
| Dec 31, 2024 | 4.05 Bn |
| Sep 30, 2024 | 4.26 Bn |
| Jun 30, 2024 | 4.79 Bn |
| Mar 31, 2024 | 4.83 Bn |
| Dec 31, 2023 | 5.24 Bn |
| Sep 30, 2023 | 6.48 Bn |
| Jun 30, 2023 | 5.80 Bn |
| Mar 31, 2023 | 4.69 Bn |
| Dec 31, 2022 | 4.12 Bn |
| Sep 30, 2022 | 4.31 Bn |
| Jun 30, 2022 | 4.44 Bn |
| Mar 31, 2022 | 3.99 Bn |
| Dec 31, 2021 | 4.20 Bn |
| Sep 30, 2021 | 4.09 Bn |
| Jun 30, 2021 | 4.44 Bn |